Homocysteine and the brain in midadult life: Evidence for an increased risk of leukoaraiosis in men

Archives of Neurology

Volumn 61, Issue 9, 2004, Pages 1369-1376

  Sachdev, Perminder ^a,b   Parslow, Ruth ^c   Salonikas, Chris ^d   Lux, Ora ^d   Wen, Wei ^a,b   Kumar, Rajeev ^c   Naidoo, Daya ^d   Christensen, Helen ^c   Jorm, Anthony ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^d New South Wales Government   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; THYROTROPIN;

ADULT; ALZHEIMER DISEASE; ARTICLE; AUSTRALIA; BRAIN; BRAIN ATROPHY; BRAIN ATROPHY INDEX; CEREBROVASCULAR DISEASE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEEP WHITE MATTER HYPERINTENSITY; DIABETES MELLITUS; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; FEMALE; FINE MOTOR SPEED; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; INFORMATION PROCESSING; LEUKOARAIOSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MOTOR ACTIVITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIVENTRICULAR WHITE MATTER HYPERINTENSITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; SCORING SYSTEM; SEX DIFFERENCE; SMOKING; THROMBOEMBOLISM; VENTRICLE BRAIN RATIO; VERBAL MEMORY;

BRAIN; BRAIN DISEASES; COGNITION; CROSS-SECTIONAL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; REGRESSION ANALYSIS; SEX FACTORS;

EID: 4444322387     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.61.9.1369     Document Type: Article

References (38)

1. Smith AD. Homocysteine, B vitamins and cognitive deficits in the elderly. Am J Clin Nutr. 2002;75:785-786.
2. Toole JF, Jack CR. Food (and vitamins) for thought. Neurology. 2002;58:1449-1450.
3. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic add intakes. JAMA. 1995;274:1049-1057.
4. Moller J, Nielsen GM, Tvedegaard KC, Andersen NT, Jorgensen PE. A meta-analysis of cerebrovascular disease and hyperhomocysteinaemia. Scand J Clin Lab Invest. 2000;60:491-500.
5. Fassbender K, Mielke O, Bertsch T, et al. Homocysteine in cerebral macroangiography and microangiopathy. Lancet. 1999;353:1586-1587.
6. Hogervorst E, Ribiero HM, Molyneux A, Budge M, Smith D. Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol. 2002;59:787-793.
7. Sachdev PS, Valenzuela M, Brodaty H, et al. Homocysteine as a risk factor for cognitive impairment in stroke patients. Dement Geriatr Cogn Disord. 2003:15:155-162.
8. Sachdev PS, Valenzuela M, Wang XL, Looi JCL, Brodaty H. Relationship between plasma homocysteine levels and brain atrophy in health elderly individuals. Neurology. 2002;58:1539-1541.
9. Bleich S, Kornhuber J. Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals. Neurology. 2003;60:1220.
10. 12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol. 1998;55:1449-1455.
11. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002:346:476-483.
12. Reutens S, Sachdev P. Homocysteine in neuropsychiatrie disorders of the elderly. Int J Geriatr Psychiatry. 2002;17:859-864.
13. Looi JCL, Sachdev P. Vascular dementia as a frontal subcortical system dysfunction. Psychol Med. 2000;30:997-1003.
14. Kado D, Selhub J, Seeman TE. Plasma total homocysteine levels and cognitive function in older high functioning adults: Macarthur Studies of Successful Aging. J Am Geriatr Soc. 2001;49:S13.
15. Kalmijin S, Launer LJ, Lindemans J, Bots ML, Hofman A, Breteler MM. Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. Am J Epidemiol. 1999;150:283-289.
16. McCaddon A, Hudson P, Davies G, Hughes A, Williams JHH, Wilkinson C. Homocysteine and cognitive decline in healthy elderly people. Dement Geriatr Cogn Disord. 2001;12:309-313.
17. Tsai JC, Perrella MA, Yoshizumi M, et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci U S A. 1994;91:6369-6373.
18. Durand P, Prost M, Loreau N, Lussier-Cacan S, Blache D. Impaired homocysteine metabolism and atherothrombotic disease. Lab Invest. 2001;81:645-672.
19. Tawakol A, Omland T, Gerhard M, Wu JT. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation. 1997;95:1119-1121.
20. Kim W-K, Pae Y-S. Involvement of N-methyl-D-aspartate receptor and free radical in homocysteine-medicated toxicity on rat cerebellar granule cells. Neurosci Lett. 1996;216:117-120.
21. Ho PI, Ortiz D, Rogers E, Shea TB. Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage. J Neurosci Res. 2002;70:694-702.
22. Kruman II, Culmsee C, Chan SL, et al. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci. 2000;20:6920-6936.
23. Vafai S, Stock JB. Protein phosphatase 2A methylation: a link between elevated plasma homocysteine and Alzheimer's disease. FEBS Lett. 2002;518:1-4.
24. Ho PI, Collins SC, Dhitavat S, et al. Homocysteine potentiates beta-amyloid neurotoxicity: role of oxidative stress. J Neurochem. 2001;78:249-253.
25. Baddeley A, Emslie H, Nimmo-Smith I. The Spot-the-Word Test. Bury St Edmunds, England: Thames Valley Test Co; 1992.
26. Victoroff J, Mack WJ, Grafton ST, Schreiber SS, Chui HC. A method to improve interrater reliability of visual inspection of brain MRI scans in dementia. Neurology. 1994;44:2267-2276.
27. Wen W, Sachdev PS. The topography of white matter hyperintensities on brain MRI in middle-aged individuals. Neuroimage. 2004;22:141-154.
28. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol. 1987;149:351-356.
29. Jorm AF, Anstey KJ, Christensen H, Rodgers B. Gender differences in cognitive abilities: the mediating role of health state and health habits. Intelligence. 2004;32:7-23.
30. Smith A. Symbol Digit Modalities Test (SDMT) Manual. Los Angeles, Calif: Western Psychological Services; 1982.
31. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test. San Antonio, Tex: Psychological Corp Harcourt Brace Jovanovich; 1987.
32. Tiffin J. Purdue Pegboard Examiner's Manual. Rosemont, III: London House; 1968.
33. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive status of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
34. den Heijer M, Vermeer SE, Clarke R, et al. Homocysteine and brain atrophy on MRI of non-demented elderly. Brain. 2003;126:170-175.
35. Williams JH, Pereira EAC, Budge MM, Bradley KM. Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people. Age Ageing. 2002;31:440-444.
36. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke. 1997;28:652-659.
37. Fazekas F, Kleinhert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43:1683-1689.
38. Takao M, Koto A, Tanahashi N, et al. Pathologic findings of silent hyperintense white matter lesions on MRI. J Neurol Sci. 1999;167:127-131.